Reduced α-2,6 sialylation regulates cell migration in endometriosis
article
OA: bronze
CC0
⤵ 18 in-corpus citations
AI-generated summary
Reduced α-2,6 sialylation in endometriosis patients' peritoneal fluid and endometriotic cells is associated with enhanced cell migration.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Is endometriosis associated with aberrant sialylation patterns and what is the potential impact of such anomalies on cell migratory properties? SUMMARY ANSWER: The reduced α-2,6 sialylation patterns in the peritoneal fluid of endometriosis-affected women and in stromal and epithelial cells from endometriotic lesions could be associated with enhanced cell migration. WHAT IS KNOWN ALREADY: Endometriosis is considered to be a benign disease although, like cancer, it has the characteristic of being an invasive disease with cells that have an enhanced capacity to migrate. Aberrant sialylation has been reported in various malignancies and it has been linked to tumour invasion and metastasis. STUDY DESIGN, SIZE, DURATION: We conducted a prospective laboratory study in a tertiary-care university hospital. We investigated non-pregnant patients who were <42 years of age (n = 273) when they underwent surgery for a benign gynaecological condition. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study population consisted of 102 women with histologically proven endometriosis and 71 endometriosis-free controls, who underwent a complete surgical exploration of the abdominopelvic cavity. Peritoneal fluids were collected during the surgical procedures, and endometrial and endometriotic biopsies were performed on all of the patients to generate stromal and epithelial primary cell cultures. The expression of α-2,6-sialyltransferase (ST6GALNAC1) was studied in eutopic and ectopic endometria of endometriosis patients and in eutopic endometria of controls by reverse transcription followed by quantitative real-time polymerase chain reaction (RT-qPCR). The α-2,6 sialylation levels were measured by ELISA in the peritoneal fluids of patients and controls and by western-blot in primary endometrial and endometriotic cell cultures using Sambucus nigra agglutinin (SNA), an α-2,6 sialic acid-binding lectin. A transwell migration assay after incubation of the cells with neuraminidase was also performed to evaluate the impact of desialylation on eutopic endometrial stromal cell migration. MAIN RESULTS AND THE ROLE OF CHANCE: ST6GALNAC1 gene expression was significantly lower in endometriotic lesions compared to that in eutopic endometrium of endometriosis-affected patients and healthy endometrium (16-fold for both; P < 0.01). We observed a significant reduction in SNA levels in the peritoneal fluids of endometriosis-affected women compared to control women (median optic density (OD), 0.257; range, 0.215-0.279 versus median OD, 0.278; range 0.238-0.285; P < 0.01), as well as in stromal (mean OD, 705 907; standard error of the mean (SEM), 141 549 versus mean OD, 1.16 × 106; SEM, 107,271; P < 0.05) and epithelial (mean OD, 485 706; SEM, 179 681 versus mean OD, 1.25 × 106; SEM, 232 120; P < 0.05) ectopic endometriotic cells compared to control eutopic cells, indicating reduced α-2,6 sialylation. Finally, in the transwell migration assay, the eutopic endometrial cells of endometriosis patients migrated significantly more into the lower chamber after incubation with neuraminidase, indicating enhanced migration by these cells after desialylation. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Our control group involved patients operated for benign gynaecological conditions (e.g. tubal infertility, uterine fibroids or ovarian cysts) which may also be associated with altered sialylation patterns. WIDER IMPLICATIONS OF THE FINDINGS: The hyposialylation pattern of endometriotic cells appeared to be associated with enhanced migratory abilities, which might contribute to the establishment of early endometriotic implants. Further research is needed to confirm these findings, as this could lead to new potential therapeutic targets for this complex disorder. STUDY FUNDING AND COMPETING INTEREST(S): No external funding was received and there are no conflicts of interest.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (53)
- Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture via openalex
- Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease via openalex
- Dysregulation of the ADAM17/Notch signalling pathways in endometriosis: from oxidative stress to fibrosis via openalex
- EGFR‐mediated matrix metalloproteinase‐7 up‐regulation promotes epithelial‐mesenchymal transition <i>via</i> ERK1‐AP1 axis during ovarian endometriosis progression via openalex
- Endometriosis of Extra-Abdominal Soft Tissues via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Epigenetic modifications of primordial reproductive tract: A common etiologic pathway for Mayer-Rokitansky-Kuster-Hauser Syndrome and endometriosis? via openalex
- Eutopic Endometrium From Women With Endometriosis Shows Altered Ultrastructure and Glycosylation Compared to That From Healthy Controls—A Pilot Observational Study via openalex
- Evading immunosurveillance in endometriosis via openalex
- Hypoxia Promotes Ectopic Adhesion Ability of Endometrial Stromal Cells via TGF-β1/Smad Signaling in Endometriosis via openalex
- Increased levels of biglycan in endometriomas and peritoneal fluid samples from ovarian endometriosis patients via openalex
- Inflammatory cytokine profile of co‑cultivated primary cells from the endometrium of women with and without endometriosis via openalex
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics via openalex
- Knockdown of E-cadherin expression of endometrial epithelial cells may activate Wnt/β-catenin pathway in vitro via openalex
- Long-chain glucosylceramides crosstalk with LYN mediates endometrial cell migration via openalex
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- Molecular Evidence for Differences in Endometrium in Severe Versus Mild Endometriosis via openalex
- Protein kinase inhibitors can control the progression of endometriosis <i>in vitro</i> and <i>in vivo</i> via openalex
- Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives via openalex
- Research Resource: Gene Expression Profile for Ectopic Versus Eutopic Endometrium Provides New Insights into Endometriosis Oncogenic Potential via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Risk of Gynecologic Cancer According to the Type of Endometriosis via openalex
- Role of the CXCL12–CXCR4 axis in the development of deep rectal endometriosis via openalex
- Role of the protein kinase BRAF in the pathogenesis of endometriosis via openalex
- Sphingosine pathway deregulation in endometriotic tissues via openalex
- Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions via openalex
- Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis via openalex
- W2111003433 via openalex
- W2108882588 via openalex
- W2107277218 via openalex
- W2413971214 via openalex
- W2106110735 via openalex
- W2560928331 via openalex
- W2594472700 via openalex
- W2100503022 via openalex
- W2057151160 via openalex
- W2056150471 via openalex
- W2765750028 via openalex
- W2053429933 via openalex
- W2037281636 via openalex
- W1986309799 via openalex
- W1970657926 via openalex
- W1182461782 via openalex
- W2891190591 via openalex
- W4211081176 via openalex
- W2136644692 via openalex
- W6680026307 via openalex
- W2142869543 via openalex
- W2168242869 via openalex
- W2216815356 via openalex
- W2229096149 via openalex
- W2116160752 via openalex
Cited by (18)
- Metabolite changes in patients with endometriosis: new potential diagnostic and therapeutic targets 2025
- Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental? 2025
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Effects of Ulipristal Acetate on Reactive Oxygen Species and Proinflammatory Cytokine Release by Epithelial and Stromal Cells from Human Endometrium and Endometriosis 2023
- Novel diagnostic options for endometriosis – Based on the glycome and microbiome 2021
- Endometriosis phenotypes are associated with specific serum metabolic profiles determined by proton-nuclear magnetic resonance 2020
Source provenance
- europepmc
- last seen: 2026-06-22T06:15:23.361955+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:23:01.605684+00:00
License: CC0
· commercial use OK